Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
More Videos
The Future of Energy Is Off-Planet, Says Aetherflux Founder Baiju Bhatt
Energy demand is soaring as AI and data centers strain the grid. Aetherflux founder Baiju Bhatt explains why space could be the next power source.
Best of CES 2026: Rise of the Robots!
From autonomous bots keeping airports running to humanoids that might become your best friend, take an exclusive look at the machines redefining how we live
From Stigma to Strategy: The Next Chapter for U.S. Cannabis Investing
Renewed investor interest and possible federal reforms may mark a turning point for U.S. cannabis. AdvisorShares’ Dan Ahrens explains what’s next.
Is Silver the Next Gold? Expert Predicts Historic Rally Ahead
Silver is back in the spotlight as supply constraints, surging industrial demand, and macro trends push prices high, possibly heading toward $100/ounce.
Is the U.S. Job Market Losing Steam? Inside the “Stall Speed” Economy
With paid job posts down 13%, LinkedIn’s Kory Kantenga explains what the latest labor data signals for workers and employers.
How Insomnia Cookies Turned Late-Night Cravings into a Global Business
What started in a college dorm is now a cookie empire. Insomnia Cookies CEO Seth Berkowitz talks scale, strategy, and staying sweet.
